PRM1 and cancer: As adenoma and inflammatory bowel disease (ulcerative colitis and Crohn`s disease) are well-accepted risk factors for CRC development [23, 24], we found increasing trend of PRM1 expression in colorectal adenoma and cancer tissues, and it is worthy to further investigate whether PRM1 can be used as an alarm marker for CRC.